特异性免疫治疗通过改善Th1/Th2免疫失衡减轻哮喘小鼠肺部炎症OACSTPCD
Specific immunotherapy alleviates lung inflammation in asthmatic mice by improving Th1/Th2 immune imbalance
目的:探讨特异性免疫治疗(SIT)对哮喘小鼠肺部炎症反应的影响及其机制.方法:小鼠按照随机数字表法分为对照组、模型组、SIT组及地塞米松组.模型组、SIT组及地塞米松组均建立哮喘小鼠模型,建模激发阶段后SIT组注射1 mg的卵白蛋白(OVA),地塞米松组灌胃0.075 mg/mL 地塞米松溶液,其余小鼠注射等体积的PBS溶液,后进入雾化阶段.采用肺功能仪检测气道反应;瑞氏-吉姆萨染色观察肺泡灌洗液(BALF)中的炎症细胞;ELISA检测BALF中细胞因子IL-13、IL-4、IL-5及干扰素-γ(IFNγ);H-E染色观察肺组织病理形态;过碘酸雪夫(PAS)染色观察肺气道上皮杯状细胞;流式细胞术检测肺组织中IFNγ及IL-4占比.结果:在6.25、12.50、25.00 μg/kg及50.00 μg/kg的乙酰胆碱作用下,模型组小鼠气道反应高于对照组,SIT组及地塞米松组的气道反应均低于模型组,但SIT组及地塞米松组间差异无统计学意义.与对照组相比,模型组小鼠BALF中细胞总数、中性粒细胞(%)、嗜酸性粒细胞(%)、IL-4、IL-5、IL-13、气道上皮杯状细胞、辅助型T细胞2(Th2)均升高,IFNγ降低;与模型组相比,SIT组BALF中细胞总数、中性粒细胞(%)、嗜酸性粒细胞(%)、IL-4、IL-5、IL-13、气道上皮杯状细胞降低,IFNγ升高,SIT组与地塞米松组间差异无统计学意义.对照组小鼠肺泡及气道结构规整,气道壁较薄,管腔无狭窄;模型组小鼠肺组织结构破坏显著,气道壁较厚,肺泡结构破坏显著,炎症浸润明显且血管周围存在水肿.SIT组及地塞米松组小鼠肺组织炎症浸润改善,血管水肿程度降低,管腔狭窄缓解.结论:SIT可缓解哮喘小鼠气道高反应性,抑制BALF中炎症细胞及炎症因子活性,通过抑制气道上皮杯状细胞增生而改善通气,其机制与改善肺组织中辅助型T细胞1/辅助型T细胞2免疫失衡相关.
Objective:To investigate the effect of specific immunotherapy(SIT)on pulmonary inflammation in asthmatic mice and its mechanism.Methods:Mice were randomly divided into control group,model group,SIT group,and dexamethasone group.Asthmatic mouse models were established in model group,SIT group,and dexamethasone group.After the modeling and stimulation stage,SIT group was injected with 1 mg OVA,dexamethasone group was injected with 0.075 mg/mL dexamethasone solution,and other rats were injected with PBS solution of equal volume,and then entered the atomization stage.Airway response was detected by pulmonary function apparatus.The inflammatory cells of alveolar lavage fluid(BALF)were observed by Reiss-Giemsa staining.The cytokines interleukin(IL)-13,IL-4,IL-5,and interferon-γ(IFNγ)in BALF were detected by enzyme-linked immunosorbent assay(ELISA).The morphology of lung tissue was observed by hematoxylin-eosin(H-E)staining.The activity of pulmonary airway epithelial goblet cells was observed by periodic acid-Schiff(PAS)staining.IFNγ and IL-4 in lung tissue were detected by flow cytometry.Results:The airway response of model group was higher than that of control group under 6.25,12.50,25.00 μg/kg and 50.00 μg/kg acetylcholine,and the airway response of SIT group and dexamethasone group were lower than that of model group,but there was no significant difference between SIT group and dexamethasone group.Compared with the control group,the total number of BALF cells,centriocytes(%),eosinophils(%),IL-4,IL-5,IL-13,airway epithelial goblet cells and helper T cells 2(Th2)in the model group were all increased,and IFNγ was decreased.The total number of BALF cells,centriocytes(%),eosinophils(%),IL-4,IL-5,IL-13 and airway epithelial goblet cells were decreased in SIT group,and IFNγ was increased.There was no significant difference between SIT group and dexamethasone group.In the control group,the alveolar and airway structures were organized,the airway walls were thin,and the lumen was not narrow.In the model group,the lung tissue structure was significantly damaged and the airway wall was thicker.The alveolar structure was destroyed,the inflammatory infiltration was obvious,and there was edema around the blood vessels.The inflammatory infiltration of lung tissue was improved,the degree of vascular edema was reduced,and the lumen stenosis was relieved in SIT group and dexamethasone group.Conclusion:SIT can relieve airway hyperplasia in asthmatic mice,inhibit the activity of inflammatory cells and inflammatory factors in the BALF,and improve ventilation by inhibiting the hyperplasia of airway epithelial goblet cells.The mechanism of improvement is related to correcting the helper T cell 1/helper T cell 2 immune imbalance in lung tissue.
张雅尚;陶俊;柯晶;陈琳;陈卓;谢辉辉;李金泉
衡水市人民医院,衡水 053000黄石市中医医院,黄石 435000
基础医学
支气管哮喘特异性免疫炎症辅助型T细胞1辅助型T细胞2
bronchial asthmaspecific immunityinflammationhelper T cells 1helper T cell 2
《解剖学杂志》 2024 (002)
126-131 / 6
国家自然科学基金(81704118);湖北省卫生健康委医学科学研究项目(WJ2019Q057)
评论